BACKGROUND: The Concorde trial compared two policies of therapy with zidovudine (ZVD) in individuals with asymptomatic HIV infection: immediate or deferred ZDV. Participants in both groups could stop their blinded trial therapy for several reasons and/or could start open-label ZDV. The difference in survival and disease progression between the two groups was estimated allowing for treatment changes. METHODS: The relationship between latest CD4 count, treatment changes and time to AIDS-related...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Impact of treatment changes on the interpretation of the Concorde trial.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record